{
  "DOI": "10.1007/s10689-007-9167-3",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-007-9167-3",
  "alternative-id": [
    "9167"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Silva",
      "given": "Edibaldo",
      "sequence": "first"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2007,
        10,
        17
      ]
    ],
    "date-time": "2007-10-17T03:57:24Z",
    "timestamp": 1192593444000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T17:45:57Z",
    "timestamp": 1559238357000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        2
      ]
    ],
    "date-time": "2023-10-02T23:57:17Z",
    "timestamp": 1696291037433
  },
  "is-referenced-by-count": 21,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2007,
        10,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2008,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2007,
            10,
            18
          ]
        ],
        "date-time": "2007-10-18T00:00:00Z",
        "timestamp": 1192665600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-007-9167-3.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-007-9167-3/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-007-9167-3",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "91-95",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2007,
        10,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2007,
        10,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1111/j.1075-122X.2004.21543.x",
      "author": "A Stolier",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "journal-title": "Breast J",
      "key": "9167_CR1",
      "unstructured": "Stolier A, Fuhrman G et al (2004) Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA1 or BRCA2 mutation. Breast J 10:475–480",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1089/gte.1997.1.85",
      "author": "A Ganguly",
      "doi-asserted-by": "crossref",
      "first-page": "85",
      "journal-title": "Genet Test",
      "key": "9167_CR2",
      "unstructured": "Ganguly A, Leahy K et al (1997) Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet Test 2:85–90",
      "volume": "2",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.2002.09.023",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "2310",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR3",
      "unstructured": "Lakhani SR, van de Vijver MJ et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers, estrogen receptor, progesterone receptor, HER-2 Neu and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310–2318",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.11688",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "1569",
      "journal-title": "Cancer",
      "key": "9167_CR4",
      "unstructured": "Foulkes WD, Metcalfe K et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98:1569–1577",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2001.19.4.924",
      "author": "CTM Brekelmans",
      "doi-asserted-by": "crossref",
      "first-page": "924",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR5",
      "unstructured": "Brekelmans CTM, Seynaeve C et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19:924–930",
      "volume": "19",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2002.20.5.1260",
      "author": "L Scheuer",
      "doi-asserted-by": "crossref",
      "first-page": "1260",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR6",
      "unstructured": "Scheuer L, Kauf N et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260–1268",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.20298",
      "author": "G Schwartz",
      "doi-asserted-by": "crossref",
      "first-page": "2512",
      "journal-title": "Cancer",
      "key": "9167_CR7",
      "unstructured": "Schwartz G, Hortogyi GN (2004) Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of breast, April 26–28, 2003, Philadelphia, Pennsylvania. Cancer 100:2512–2532",
      "volume": "100",
      "year": "2004"
    },
    {
      "DOI": "10.1093/oxfordjournals.jncimonographs.a003469",
      "author": "N Wolmark",
      "doi-asserted-by": "crossref",
      "first-page": "96",
      "journal-title": "J Natl Cancer Inst Monogr",
      "key": "9167_CR8",
      "unstructured": "Wolmark N, Wang J, Mamounas E et al (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from NSABP B-18. J Natl Cancer Inst Monogr 30:96–102",
      "volume": "30",
      "year": "2001"
    },
    {
      "DOI": "10.1111/j.1075-122X.2006.00261.x",
      "author": "B Cady",
      "doi-asserted-by": "crossref",
      "first-page": "282",
      "journal-title": "Breast J",
      "key": "9167_CR9",
      "unstructured": "Cady B, Chung M et al (2006) Re: genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations. Breast J 12:282–283",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1053/sonc.2001.26150",
      "author": "EP Mammounas",
      "doi-asserted-by": "crossref",
      "first-page": "389",
      "journal-title": "Semin Oncol",
      "key": "9167_CR10",
      "unstructured": "Mammounas EP, Fisher B (2001) Preoperative (neoadjuvant) chemotherapy in patients with breast cancer. Semin Oncol 28:389–399",
      "volume": "28",
      "year": "2001"
    },
    {
      "DOI": "10.1053/j.sembd.2005.01.002",
      "author": "V Tsikitis",
      "doi-asserted-by": "crossref",
      "first-page": "51",
      "journal-title": "Semin Breast Dis",
      "key": "9167_CR11",
      "unstructured": "Tsikitis V, Chung M et al (2004) Scientific basis of neoadjuvant therapy. Semin Breast Dis 7:51–57",
      "volume": "7",
      "year": "2004"
    },
    {
      "DOI": "10.1046/j.1524-4741.2003.09624.x",
      "author": "E Warner",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "journal-title": "Practical implications. Breast J",
      "key": "9167_CR12",
      "unstructured": "Warner E, Trudeau M et al (2003) Sensitivity of BRCA1-related breast cancer to neoadjuvant chemotherapy. Practical implications. Breast J 9:507–508",
      "volume": "9",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2000.18.19.3360",
      "author": "LJ Pierce",
      "doi-asserted-by": "crossref",
      "first-page": "3360",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR13",
      "unstructured": "Pierce LJ, Struderman M et al (2000) Effect of radiotherapy after breast conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18:3360–3369",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1016/S0140-6736(02)08434-9",
      "author": "B Hafty",
      "doi-asserted-by": "crossref",
      "first-page": "1471",
      "journal-title": "Lancet",
      "key": "9167_CR14",
      "unstructured": "Hafty B, Harrold E et al (2002) Outcome of conservatively managed early onset breast cancer by BRCA1/2 status. Lancet 359:1471–1477",
      "volume": "359",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.20221",
      "author": "IK Komenaka",
      "doi-asserted-by": "crossref",
      "first-page": "2079",
      "journal-title": "Cancer",
      "key": "9167_CR15",
      "unstructured": "Komenaka IK, Ditkoff BA et al (2004) The development of interval breast malignancies in patients with BRCA mutations. Cancer 100:2079–2083",
      "volume": "100",
      "year": "2004"
    },
    {
      "DOI": "10.1097/01.prs.0000201478.64877.87",
      "author": "JA Ascherman",
      "doi-asserted-by": "crossref",
      "first-page": "359",
      "journal-title": "Plast Reconstr Surg",
      "key": "9167_CR16",
      "unstructured": "Ascherman JA, Hanasono MM et al (2006) Implant reconstruction in breast cancer patients treated with radiation therapy. Plast Reconstr Surg 117:359–365",
      "volume": "117",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.10.035",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "1656",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR17",
      "unstructured": "Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJM199901143400201",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "77",
      "journal-title": "N Engl J Med",
      "key": "9167_CR18",
      "unstructured": "Hartmann LC, Schaid DJ (1999) Effect of bilateral prophylactic mastectomy in women with a familial history of breast cancer. N Engl J Med 340:77–84",
      "volume": "340",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "crossref",
      "first-page": "1633",
      "journal-title": "J Natl Cancer Inst",
      "key": "9167_CR19",
      "unstructured": "Hartmann LC, Sellers TA et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633–1637",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1200/JCO.2005.08.903",
      "author": "M Schwartz",
      "doi-asserted-by": "crossref",
      "first-page": "7777",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR20",
      "unstructured": "Schwartz M (2005) Contralateral prophylactic mastectomy: efficacy, satisfaction, regret. J Clin Oncol 23:7777–7779",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR21",
      "unstructured": "Rebbeck TR, Friebel T et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers. The PROSE Study Group. J Clin Oncol 221:1055–1062",
      "volume": "221",
      "year": "2004"
    },
    {
      "DOI": "10.1056/NEJM200107193450301",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "journal-title": "N Engl J Med",
      "key": "9167_CR22",
      "unstructured": "Meijers-Heijboer H, van Geel B et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 or BRCA2 mutations. N Engl J Med 345:159–164",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.295.12.1379",
      "author": "T Walsh",
      "doi-asserted-by": "crossref",
      "first-page": "1379",
      "journal-title": "JAMA",
      "key": "9167_CR23",
      "unstructured": "Walsh T, Casadei S et al (2006) Spectrum of mutations in BRCA1, BRCA2, chek2, and TP53 in families at high risk of breast cancer. JAMA 295:1379–1387",
      "volume": "295",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2000.18.9.1980",
      "author": "A Eisen",
      "doi-asserted-by": "crossref",
      "first-page": "1980",
      "journal-title": "J Clin Oncol",
      "key": "9167_CR24",
      "unstructured": "Eisen A, Rebbeck TR et al (2000) Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 18:1980–1995",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa012158",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1616",
      "journal-title": "N Engl J Med",
      "key": "9167_CR25",
      "unstructured": "Rebbeck TR, Lynch HT et al (2002) Prophylactic oophorectomy in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 346:1616–1621",
      "volume": "346",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jmg.40.8.591",
      "author": "P Watson",
      "doi-asserted-by": "crossref",
      "first-page": "591",
      "journal-title": "J Med Genet",
      "key": "9167_CR26",
      "unstructured": "Watson P, Narod SA et al (2003) Carrier risk status changes resulting form mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast ovarian cancer. J Med Genet 40:591–596",
      "volume": "40",
      "year": "2003"
    }
  ],
  "reference-count": 26,
  "references-count": 26,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-007-9167-3"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist"
  ],
  "type": "journal-article",
  "volume": "7"
}